|
1
|
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
|
Endocr Rev
|
2004
|
3.79
|
|
2
|
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
|
Lancet Oncol
|
2008
|
2.32
|
|
3
|
Hypopituitarism.
|
Lancet
|
2007
|
2.27
|
|
4
|
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
|
J Cell Biol
|
2002
|
1.97
|
|
5
|
Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review.
|
JAMA
|
2007
|
1.59
|
|
6
|
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
|
Eur J Endocrinol
|
2005
|
1.59
|
|
7
|
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology.
|
Clin Chem Lab Med
|
2014
|
1.49
|
|
8
|
Endocrine function is altered in chronic migraine patients with medication-overuse.
|
Headache
|
2006
|
1.47
|
|
9
|
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors.
|
J Clin Endocrinol Metab
|
2002
|
1.45
|
|
10
|
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.
|
Endocrinology
|
2006
|
1.43
|
|
11
|
Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes.
|
J Clin Endocrinol Metab
|
2004
|
1.39
|
|
12
|
Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways.
|
FASEB J
|
2004
|
1.32
|
|
13
|
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study.
|
J Clin Endocrinol Metab
|
2005
|
1.32
|
|
14
|
Extracellular vesicles as an emerging mechanism of cell-to-cell communication.
|
Endocrine
|
2012
|
1.32
|
|
15
|
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury.
|
Clin Endocrinol (Oxf)
|
2004
|
1.29
|
|
16
|
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
|
Cardiovasc Res
|
2009
|
1.26
|
|
17
|
Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.
|
J Clin Endocrinol Metab
|
2012
|
1.24
|
|
18
|
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity.
|
Eur J Pharmacol
|
2002
|
1.24
|
|
19
|
Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
|
Diabetes
|
2007
|
1.22
|
|
20
|
The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects.
|
J Clin Endocrinol Metab
|
2003
|
1.12
|
|
21
|
Unraveling the role of the ghrelin gene peptides in the endocrine pancreas.
|
J Mol Endocrinol
|
2010
|
1.09
|
|
22
|
Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.06
|
|
23
|
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines.
|
Eur J Endocrinol
|
2004
|
1.05
|
|
24
|
Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy.
|
Obes Res
|
2002
|
1.04
|
|
25
|
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations.
|
Nutr Metab Cardiovasc Dis
|
2005
|
1.03
|
|
26
|
Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone.
|
Exp Biol Med (Maywood)
|
2011
|
1.02
|
|
27
|
A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
|
Bone
|
2008
|
1.01
|
|
28
|
The IGF system.
|
Acta Diabetol
|
2010
|
1.01
|
|
29
|
Neuroendocrine alterations in obese patients with sleep apnea syndrome.
|
Int J Endocrinol
|
2010
|
1.01
|
|
30
|
Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
|
Eur J Pharmacol
|
2004
|
1.01
|
|
31
|
Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables.
|
Clin Endocrinol (Oxf)
|
2003
|
1.01
|
|
32
|
Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes.
|
Eur J Endocrinol
|
2009
|
1.00
|
|
33
|
Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor.
|
Mol Cell Endocrinol
|
2006
|
0.99
|
|
34
|
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin.
|
Eur J Pharmacol
|
2003
|
0.98
|
|
35
|
Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans.
|
Clin Endocrinol (Oxf)
|
2003
|
0.97
|
|
36
|
Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells.
|
Endocrinology
|
2008
|
0.96
|
|
37
|
Endocrine and metabolic responses to extreme altitude and physical exercise in climbers.
|
Eur J Endocrinol
|
2007
|
0.95
|
|
38
|
Ghrelin secretion in childhood is refractory to the inhibitory effect of feeding.
|
J Clin Endocrinol Metab
|
2004
|
0.95
|
|
39
|
Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes.
|
Diabetes
|
2010
|
0.95
|
|
40
|
Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults.
|
Eur J Endocrinol
|
2007
|
0.94
|
|
41
|
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.
|
J Clin Endocrinol Metab
|
2014
|
0.94
|
|
42
|
The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
|
Endocrinology
|
2002
|
0.93
|
|
43
|
Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
|
Clin Endocrinol (Oxf)
|
2011
|
0.93
|
|
44
|
Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms.
|
Endocrinology
|
2007
|
0.92
|
|
45
|
Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
|
Neuroendocrinology
|
2007
|
0.92
|
|
46
|
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans.
|
Clin Endocrinol (Oxf)
|
2004
|
0.92
|
|
47
|
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.
|
Eur J Endocrinol
|
2009
|
0.91
|
|
48
|
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation.
|
FASEB J
|
2012
|
0.91
|
|
49
|
Association of craniopharyngioma and pituitary adenoma.
|
Endocrine
|
2013
|
0.88
|
|
50
|
Ghrelin drives GH secretion during fasting in man.
|
Eur J Endocrinol
|
2002
|
0.88
|
|
51
|
Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats.
|
J Mol Endocrinol
|
2010
|
0.88
|
|
52
|
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
|
J Clin Endocrinol Metab
|
2002
|
0.88
|
|
53
|
GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.
|
Endocrinology
|
2013
|
0.88
|
|
54
|
Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
|
J Clin Endocrinol Metab
|
2008
|
0.87
|
|
55
|
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo.
|
Endocrinology
|
2002
|
0.87
|
|
56
|
Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth.
|
Am J Pathol
|
2003
|
0.87
|
|
57
|
Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism?
|
Eur J Endocrinol
|
2006
|
0.87
|
|
58
|
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome.
|
Pituitary
|
2004
|
0.87
|
|
59
|
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
|
Eur J Endocrinol
|
2010
|
0.86
|
|
60
|
Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression.
|
J Am Heart Assoc
|
2013
|
0.86
|
|
61
|
Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement.
|
Eur J Endocrinol
|
2005
|
0.86
|
|
62
|
The nutritional control of ghrelin secretion in humans: the effects of enteral vs. parenteral nutrition.
|
Eur J Nutr
|
2006
|
0.86
|
|
63
|
The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
|
Clin Endocrinol (Oxf)
|
2002
|
0.85
|
|
64
|
Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults.
|
Eur J Endocrinol
|
2012
|
0.85
|
|
65
|
GPR103b functions in the peripheral regulation of adipogenesis.
|
Mol Endocrinol
|
2010
|
0.85
|
|
66
|
Ghrelin and anterior pituitary function.
|
Front Horm Res
|
2010
|
0.85
|
|
67
|
Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy.
|
Eur J Endocrinol
|
2011
|
0.84
|
|
68
|
Ghrelin and the endocrine pancreas.
|
Endocrine
|
2003
|
0.84
|
|
69
|
Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
|
J Clin Endocrinol Metab
|
2005
|
0.84
|
|
70
|
Hypopituitarism following brain injury: when does it occur and how best to test?
|
Pituitary
|
2012
|
0.84
|
|
71
|
Endocrine actions of cortistatin: in vivo studies.
|
Mol Cell Endocrinol
|
2007
|
0.84
|
|
72
|
Myocardial insulin-like growth factor-1 and insulin-like growth factor binding protein-3 gene expression in failing hearts harvested from patients undergoing cardiac transplantation.
|
J Heart Lung Transplant
|
2009
|
0.84
|
|
73
|
Acetylcholine regulates ghrelin secretion in humans.
|
J Clin Endocrinol Metab
|
2004
|
0.84
|
|
74
|
Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation.
|
Endocrinology
|
2005
|
0.83
|
|
75
|
BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.
|
Clin Endocrinol (Oxf)
|
2012
|
0.83
|
|
76
|
Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity.
|
Clin Endocrinol (Oxf)
|
2002
|
0.83
|
|
77
|
Impact of snacking pattern on overweight and obesity risk in a cohort of 11- to 13-year-old adolescents.
|
J Pediatr Gastroenterol Nutr
|
2014
|
0.83
|
|
78
|
Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal.
|
Eur J Endocrinol
|
2008
|
0.83
|
|
79
|
Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans.
|
J Clin Endocrinol Metab
|
2004
|
0.83
|
|
80
|
Ghrelin: much more than a natural growth hormone secretagogue.
|
Isr Med Assoc J
|
2002
|
0.83
|
|
81
|
Endocrine and non-endocrine actions of ghrelin.
|
Horm Res
|
2003
|
0.83
|
|
82
|
Des-acyl ghrelin fragments and analogues promote survival of pancreatic β-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats.
|
J Med Chem
|
2012
|
0.82
|
|
83
|
GHRH and GH secretagogues: clinical perspectives and safety.
|
Pediatr Endocrinol Rev
|
2004
|
0.82
|
|
84
|
Growth hormone treatment in human ageing: benefits and risks.
|
Hormones (Athens)
|
2008
|
0.81
|
|
85
|
Endocrine and metabolic actions of ghrelin.
|
Endocr Dev
|
2009
|
0.81
|
|
86
|
Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA-, mineralocorticoid-, and GH-Secretagogue-receptor modulation.
|
ScientificWorldJournal
|
2006
|
0.81
|
|
87
|
Variations of pituitary function over time after brain injuries: the lesson from a prospective study.
|
Pituitary
|
2005
|
0.81
|
|
88
|
Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing's disease.
|
Eur J Endocrinol
|
2011
|
0.81
|
|
89
|
Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility.
|
Hum Reprod
|
2012
|
0.81
|
|
90
|
Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood.
|
Pituitary
|
2007
|
0.81
|
|
91
|
Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans.
|
Endocrine
|
2012
|
0.80
|
|
92
|
Ghrelin: a new hormone with endocrine and non-endocrine activities.
|
Pediatr Endocrinol Rev
|
2004
|
0.80
|
|
93
|
Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
|
Clin Endocrinol (Oxf)
|
2004
|
0.80
|
|
94
|
In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues.
|
Eur J Pharm Sci
|
2012
|
0.79
|
|
95
|
Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in female primates and male/female mice.
|
Endocrinology
|
2014
|
0.79
|
|
96
|
Brain-gut communication: cortistatin, somatostatin and ghrelin.
|
Trends Endocrinol Metab
|
2007
|
0.79
|
|
97
|
Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
|
J Clin Endocrinol Metab
|
2002
|
0.79
|
|
98
|
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences.
|
Semin Vasc Med
|
2004
|
0.79
|
|
99
|
Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
|
Eur J Endocrinol
|
2013
|
0.79
|
|
100
|
Paediatric pituitary adenomas: a decade of change.
|
Horm Res Paediatr
|
2014
|
0.79
|
|
101
|
PubMed search strategies for the identification of etiologic associations between hypothalamic-pituitary disorders and other medical conditions.
|
Pituitary
|
2013
|
0.78
|
|
102
|
Intravenous glucose administration in fasting rats has differential effects on acylated and unacylated ghrelin in the portal and systemic circulation: a comparison between portal and peripheral concentrations in anesthetized rats.
|
Endocrinology
|
2007
|
0.78
|
|
103
|
Tall stature without growth hormone: four male patients with aromatase deficiency.
|
J Clin Endocrinol Metab
|
2010
|
0.78
|
|
104
|
Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa.
|
Eur J Endocrinol
|
2006
|
0.78
|
|
105
|
Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
|
Clin Endocrinol (Oxf)
|
2002
|
0.78
|
|
106
|
Neuroendocrine effects of citalopram infusion in anorexia nervosa.
|
Psychoneuroendocrinology
|
2006
|
0.78
|
|
107
|
Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways.
|
PLoS One
|
2013
|
0.78
|
|
108
|
Obestatin: is it really doing something?
|
Front Horm Res
|
2014
|
0.78
|
|
109
|
Traumatic brain injury and hypopituitarism.
|
ScientificWorldJournal
|
2005
|
0.78
|
|
110
|
Insulin-like growth factor I levels and the diagnosis of adult growth hormone deficiency.
|
Horm Res
|
2004
|
0.78
|
|
111
|
Glucose metabolism in patients with subclinical Cushing's syndrome.
|
Endocrine
|
2012
|
0.77
|
|
112
|
Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects.
|
J Clin Endocrinol Metab
|
2010
|
0.77
|
|
113
|
Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea.
|
Gynecol Endocrinol
|
2011
|
0.77
|
|
114
|
Obestatin: a new metabolic player in the pancreas and white adipose tissue.
|
IUBMB Life
|
2013
|
0.77
|
|
115
|
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
|
Clin Endocrinol (Oxf)
|
2003
|
0.77
|
|
116
|
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
|
Clin Endocrinol (Oxf)
|
2002
|
0.77
|
|
117
|
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome.
|
Clin Endocrinol (Oxf)
|
2014
|
0.77
|
|
118
|
Neuroendocrine and metabolic activities of ghrelin gene products.
|
Peptides
|
2011
|
0.77
|
|
119
|
Ghrelin and synthetic GH secretagogues.
|
Best Pract Res Clin Endocrinol Metab
|
2002
|
0.77
|
|
120
|
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
|
Eur J Pharmacol
|
2002
|
0.77
|
|
121
|
Traumatic brain injury and hypopituitarism in children and adolescents: is the problem under-estimated?
|
Pediatr Endocrinol Rev
|
2007
|
0.77
|
|
122
|
Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
|
Clin Endocrinol (Oxf)
|
2004
|
0.77
|
|
123
|
Testing pituitary function in aging individuals.
|
Endocrinol Metab Clin North Am
|
2005
|
0.77
|
|
124
|
GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections.
|
Eur J Endocrinol
|
2007
|
0.77
|
|
125
|
The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
|
Fertil Steril
|
2009
|
0.77
|
|
126
|
Ghrelin: endocrine and non-endocrine actions.
|
J Pediatr Endocrinol Metab
|
2002
|
0.76
|
|
127
|
Other than growth hormone neuroendocrine actions of ghrelin.
|
Endocr Dev
|
2013
|
0.76
|
|
128
|
GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
|
J Clin Endocrinol Metab
|
2002
|
0.76
|
|
129
|
GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses.
|
Eur J Endocrinol
|
2013
|
0.76
|
|
130
|
The effectiveness of arginine + GHRH test compared with GHRH + GHRP-6 test in diagnosing growth hormone deficiency in adults.
|
Clin Endocrinol (Oxf)
|
2003
|
0.76
|
|
131
|
Managing patients with hypopituitarism after traumatic brain injury.
|
Curr Opin Endocrinol Diabetes Obes
|
2007
|
0.76
|
|
132
|
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours.
|
J Pathol
|
2005
|
0.76
|
|
133
|
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B.
|
Biochim Biophys Acta
|
2011
|
0.76
|
|
134
|
Targeting the ghrelin receptor: orally active GHS and cortistatin analogs.
|
Endocrine
|
2003
|
0.76
|
|
135
|
Intracoronary ghrelin infusion decreases coronary blood flow in anesthetized pigs.
|
Endocrinology
|
2006
|
0.76
|
|
136
|
Should every patient with traumatic brain injury be referred to an endocrinologist?
|
Nat Clin Pract Endocrinol Metab
|
2007
|
0.76
|
|
137
|
Products of the ghrelin gene, the pancreatic β-cell and the adipocyte.
|
Endocr Dev
|
2013
|
0.76
|
|
138
|
Pyroglutamylated RF-amide peptide (QRFP) gene is regulated by metabolic endotoxemia.
|
Mol Endocrinol
|
2013
|
0.75
|
|
139
|
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease.
|
Eur J Endocrinol
|
2005
|
0.75
|
|
140
|
The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic--pituitary--adrenal (HPA) axis in humans.
|
Pituitary
|
2013
|
0.75
|
|
141
|
Somatostatin, cortistatin and their receptors in health and disease. Foreword.
|
Mol Cell Endocrinol
|
2008
|
0.75
|
|
142
|
Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
|
Eur J Endocrinol
|
2002
|
0.75
|
|
143
|
Pituitary Autoimmunity.
|
Front Horm Res
|
2017
|
0.75
|
|
144
|
Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly.
|
Eur J Endocrinol
|
2002
|
0.75
|
|
145
|
Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing's syndrome.
|
Pituitary
|
2013
|
0.75
|
|
146
|
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans.
|
J Clin Endocrinol Metab
|
2009
|
0.75
|
|
147
|
Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
|
Clin Endocrinol (Oxf)
|
2006
|
0.75
|
|
148
|
Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
|
Neuroendocrinology
|
2002
|
0.75
|
|
149
|
Secondary Adrenal Insufficiency: Where Is It Hidden and What Does It Look Like?
|
Front Horm Res
|
2016
|
0.75
|
|
150
|
Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
|
Clin Endocrinol (Oxf)
|
2003
|
0.75
|
|
151
|
Hypopituitarism is a common neuro-endocrine disease: how manage to inform the medical community.
|
Pituitary
|
2005
|
0.75
|
|
152
|
IGFs and IGFBPs in adult growth hormone deficiency.
|
Endocr Dev
|
2005
|
0.75
|
|
153
|
Court dwarfs: an overview of European paintings from fifteenth to eighteenth century.
|
Endocrine
|
2012
|
0.75
|
|
154
|
Identification of risk conditions for the development of adrenal disorders: how optimized PubMed search strategies makes the difference.
|
Endocrine
|
2014
|
0.75
|
|
155
|
Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion.
|
Eur J Endocrinol
|
2013
|
0.75
|